This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Knudsen, A. B. Articles by Gazelle, G. S. Search for Related Content PubMed PubMed Citation Articles by Knudsen, A. B. Articles by Gazelle, G. S. Social Bookmarking                            What's this?

Use of Modeling to Evaluate the Cost-Effectiveness of Cancer Screening Programs

Amy B. Knudsen, Pamela M. McMahon, G. Scott Gazelle

From the Harvard Medical School and Massachusetts General Hospital, Boston, MA

Address reprint requests to G. Scott Gazelle, MD, MPH, PhD, Institute for Technology Assessment, 101 Merrimac St 10th floor, Boston, MA 02114; e-mail: scott{at}mgh-ita.org

Cost-effectiveness analysis (CEA) is an analytic tool that provides a framework for comparing the health benefits and resource expenditures associated with competing medical and public health interventions, thereby allowing decision makers to identify interventions that yield the greatest amount of health, given their resource constraints. Models are important components of most, if not all, CEAs, and they play a key role in evaluating the cost-effectiveness of cancer screening programs, in particular. In this article, we describe the basic types of models used to evaluate cancer screening programs and provide examples of the use of models in CEAs and to guide cancer screening policy. Finally, we offer some suggestions for important concepts to consider when interpreting model results.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. M. McMahon, C. Y. Kong, B. E. Johnson, M. C. Weinstein, J. C. Weeks, K. M. Kuntz, J.-A. O. Shepard, S. J. Swensen, and G. S. Gazelle Estimating Long-term Effectiveness of Lung Cancer Screening in the Mayo CT Screening Study Radiology, July 1, 2008; 248(1): 278 - 287. [Abstract] [Full Text] [PDF]

				N. J. Meropol and K. A. Schulman Perspectives on the Cost of Cancer Care J. Clin. Oncol., January 10, 2007; 25(2): 169 - 170. [Full Text] [PDF]

				N. J. Meropol and K. A. Schulman Cost of Cancer Care: Issues and Implications J. Clin. Oncol., January 10, 2007; 25(2): 180 - 186. [Abstract] [Full Text] [PDF]